Trading on the OTCBB, Fresh Start Private Management Inc. is an alcohol addiction, alcohol withdrawal, alcohol abuse treatment and alcohol detox rehabilitation company on the leading edge of alcohol addiction treatment. The Company has licensed a highly effective treatment that delivers target therapeutic levels of Naltrexone that significantly reduce patients’ cravings for alcohol. Fresh Start Private Management Inc. has their headquarters in Santa Ana, California.

Fresh Start Private was founded in Australia by Neil Muller and Dr. George O’Neil in 2004. They founded the Company to provide global access to the innovative addiction treatment work pioneered by Dr. O’Neil through his initial Fresh Start clinic. The Company has significant experience in alcohol addiction treatment and they have successfully treated more than 5,000 addiction patients (both drug and alcohol). They have created a uniquely comprehensive alcohol treatment program that incorporates all of the essential elements for successful alcohol addiction recovery.

Fresh Start Private is the only alcohol treatment program to offer a single-administration, licensed long acting, Naltrexone implant procedure. Naltrexone has approval for use by the FDA within the United States for the treatment of alcohol.

Trained medical doctors insert a specially formulated, biodegradable naltrexone implant just beneath the skin below the patient’s lower abdominal area. The procedure is done quickly and requires only local anesthetic. The implant significantly reduces one’s cravings for alcohol, giving them the opportunity to deal with their alcohol addiction without wanting a drink.

The patented product is a state-of-the-art medical procedure. There is no downtime for alcohol addiction treatment. A patient can return home and resume work the same day. The Company’s procedure tackles the physical aspect of alcoholism. They offer continuing care for patients and family upon return home.

In late November 2010, Fresh Start Private announced that their first facility is operational. The facility is able to treat up to 15 patients a day with potential revenue of $120 Million per year per clinic. Their fully licensed and certified medical facility has three treatment rooms that are each able to process up to five patients per day.

In December 2010, Fresh Start Private Management Inc. provided data showing that Naltrexone is effective in the treatment of alcoholism. According to published results in the Oxford Journals, research indicated, “Naltrexone is superior to placebo. Subjects treated with Naltrexone experience significantly fewer episodes of relapse, and significantly more remain abstinent when compared to placebo-treated subjects {risk difference of relapse rates = -14% [95% confidence interval (CI): -23%, -5%]; and risk difference of abstinence rates = 10% (95% CI: 4%, 16%)} after 12 weeks of treatment. The Naltrexone-treated subjects also consume significantly less alcohol over the study period than do placebo-treated subjects.”

In late January, Fresh Start Private announced that their partner Merit Management Services, LLC (Merit) opened their first clinic on the East Coast of the U.S. in Danbury, Connecticut. This first facility is now operational and able to treat up to 5 patients a day with potential revenue of $10 Million per year.

This week, Fresh Start Private announced that they have been contacting various health and medical insurance providers to work with them on providing coverage for their alcohol treatment program. Some of the insurance providers the Company intends to contact include Blue Cross and Blue Shield Association, Humana Health Insurance, Cigna Health Insurance, UnitedHealth Group Insurance, and ValueOptions® Behavioral Health Care. Their intent is to provide their patients with various payment options thereby increasing sales channels to multiple demographic contingents across the spectrum.